NASDAQ:FREQ
Delisted

Frequency Therapeutics Stock Signals

etoro logo Buy FREQ
*Your capital is at risk
$0.300
+0 (+0%)
At Close: Feb 02, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for Frequency Therapeutics Inc.

General

Signal Type Signal Value Data
Score 0.000 60 days ( 0 %
Last Price $0.300 0 %
Performance History
7 Days
$0.300 $0.300
0%
30 Days
$0.300 $0.300
0%
12 Mos
$4.17 $0.300
-92.81%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 45.27
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.300 - $0.300
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Feb 01, 2024 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 16, 2023 - 53 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Buy Medium Nov 08, 2023 - 59 days
Short/Long MA 3 mos Buy Medium Nov 09, 2023 - 58 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 20.08
Signal Type Signal Value Importance Data
Trend - 12 mos -65.35 % Very High Width: 262.46 %
Pred. range - 12 mos N/A - $0.146 High -100.00 % - -51.32 %
Short MA 12 mos Buy Very High Nov 01, 2023 - 64 days
Long MA 12 mos Sell Very High Sep 01, 2023 - 106 days
Short/Long MA 12 mos Sell Very High Sep 19, 2023 - 95 days
Pivot Long Sell Low Feb 01, 2024 - 2 days
RSI Long Pivot Signal Sell Low Nov 28, 2023 - 46 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT FREQUENCY THERAPEUTICS INC.
Frequency Therapeutics
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hea...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE